401(k) · DOL Form 5500 · 2023

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan

Data updated 2026-08-25

$64M
Total assets Below avg plan size: 334
Participants Below avg headcount: 88th
Percentile by assets National rank: $190,471
Avg per participant Above avg balance/head

PlainRetire home → About this data RSS: change history

Official DOL plan name: Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan · Sponsored by Hematology-Oncology Associates of Central New York, P.C. · New York · Healthcare & Social Assistance

$64M in assets, 334 participants

Hematology-Oncology Associates of Central New York, P.C.'s Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan reported $64M in total assets and 334 participants in its 2023 DOL Form 5500 filing, ranking in the 88th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

#15,843 in Healthcare & Social Assistance (17,684 peers)

Coverage in New York

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan covers 334 participants in New York, about 42% of the average New York filer (state average ~798 per filing). Assets: $64M.

#15,843
in Healthcare & Social Assistance (17,684 peers): +17.0%
assets growth YoY: 0.6×
vs typical plan assets (national mean)

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan's outsized position by total assets

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan vs every filed plan by assets

End-of-year total assets · plan year 2023 · DOL Form 5500

$63,617,228 Top 12% higher than 88% of 127,068 filed plans

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2023

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan among mid-size filed plans by headcount

Plan-year 2023 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan sits mid-pack in the medium band (334 participants).

Micro (1-10) 35,718 filings (27%) Small (11-100) 27,089 filings (21%) Medium (101-1,000) 55,445 filings (43%) Large (1,001-10,000) 10,273 filings (8%) Mega (10,000+) 1,374 filings (1%)

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan reported net income rose from -$6M in the plan year 2022 filing to $9M in the plan year 2023 filing.
Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan end-of-year assets rose from $54M in the plan year 2022 filing to $64M in the plan year 2023 filing.
Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan reported participants rose from 319 in the plan year 2022 filing to 334 in the plan year 2023 filing.

See the national 2022→2023 release diff →

DOL schedule card

Filing strip 161184100 · Hematology-Oncology Associates of Central New York, P.C. PY 2023 · 401(k)

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan · $64M · 334 · 88th

PCT $64M
EIN 334
RANK 88th
PHOTO 401(k)
IND near Valtir 401(k) Plan
EOY ind #15843

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Healthcare & Social Assistance retirement plans → · Plans in New York →

End-of-year total assets ($M) among Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2023.

New York filing particulars

Total Assets (Beginning of Year)	$54M
Net Assets (End of Year)	$64M
Net Income	$9M
Employer EIN	161184100
Plan Effective Date	1984-08-01
Filing Status	FILING RECEIVED

Sponsor Plan History (Hematology-Oncology Associates of Central New York, P.C.)

Latest sponsor-wide plan assets: $73M 34.42406784652479% vs 2022; 2024 filing year

Year	Plans	Participants	Total Assets
2022	1	319	$54M
2023	1	334	$64M
2024	1	347	$73M

Nearby 401(k) Plans in New York

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan vs. nearby 401(k) plans in New York, assets vs. participants

IBM 401 (K) Plus Plan $57.4B · 54,912
Pfizer Savings Plan $19.6B · 30,033
Morgan Stanley 401(k) Plan $19.2B · 55,363
The Pepsico Savings Plan $13.7B · 133,597
The Goldman Sachs 401(k) Plan $11.4B · 24,866

Compare Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan side-by-side with 3 peers →

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan's out-of-state 401(k) peers by assets and headcount

Outside New York, the nearest 401(k) by assets is Valtir 401(k) Plan in TX ($64M); by covered participants it is Investment Corporation of Palm Beach 401(k) Plan in FL (334 participants). Same-state nearby plans are listed separately above.

Closest by plan assets

Nearest other-state filings by tot_assets_eoy ($64M here).

Valtir 401(k) Plan (TX) $64M · 615
Slr International Corporation 401(k) Savings Plan (WA) $64M · 450
Universal Display Corporation 401(k) Plan (NJ) $64M · 359
Rothwell, Figg, Ernst & Manbeck 401(k) Profit Sharing Plan (DC) $64M · 83

Similar participant headcount

Nearest other-state filings by covered participants (334 participants); asset peers above are excluded.

Investment Corporation of Palm Beach 401(k) Plan (FL) 334 · 0 off
Airmar Technology Corporation 401(k) Plan (NH) 334 · 0 off
Profit Sharing Retirement Plan for Employees of Res and Kondex (WI) 334 · 0 off
Tarrytown Expocare 401(k) Plan (TX) 334 · 0 off

DOL Form 5500 plan year 2023. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan assets move in 2023? ▼

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan grew sharply - up 17.0% during 2023, from $54M to $64M. Reported net income was $9M.

How have Hematology-Oncology Associates of Central New York, P.C. plan assets changed over time? ▼

Across 3 plan years on file (2022-2024), Hematology-Oncology Associates of Central New York, P.C.'s sponsor-wide assets grew 34.4%, from $54M to $73M.

Where does Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan rank by assets among Form 5500 filers? ▼

Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan ranks in the 88th percentile by end-of-year assets among 127,072 plans that reported assets for plan year 2023 (in the top quartile of all filed plans by assets).

Which 401(k) plans are similar in size to Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan? ▼

Among 401(k) plans in other states, the closest by assets is Valtir 401(k) Plan in TX ($64M, 615 participants).

Which 401(k) plans cover a similar participant headcount to Hematology-Oncology Associates of Central New York, P.C. 401(k) Plan? ▼

Among 401(k) plans in other states, the closest by covered participants is Investment Corporation of Palm Beach 401(k) Plan in FL (334 participants, $12M in assets).

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 161184100.